SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as it hits a 12-year low, with the community sharply divided over whether the stock represents a deep-value opportunity for patient dividend seekers or a failing brand facing long-term structural decline. Investors are debating the impact of aggressive short-selling activity and leadership skepticism against the potential for an eventual turnaround.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as investors weigh strong revenue growth projections against concerns over potential share dilution and a lack of transparency regarding earnings release dates. The community remains deeply divided, with bulls pointing to the company's expansion into AI infrastructure as a massive long-term catalyst, while bears emphasize historical volatility and management's reliance on convertible financing.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is trending due to its recent confirmation of strong 2026 revenue expectations, bolstered by major five-year hosting agreements with Axe Compute valued over $500 million. Investors are actively debating the company's aggressive infrastructure expansion in the AI data center sector, weighing the significance of these large-scale contract wins against the potential for shareholder dilution and execution risks.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is currently trending as investors weigh its attractive valuation and strong brand presence against concerns over retail sector headwinds and leadership transitions. While some market participants see an entry point for a potential turnaround, others are voicing caution regarding mounting competition and shifting consumer spending habits.

Fabrinet engages in the provision of optical packaging and electronic manufacturing services to original equipment manufacturers. The firm's engineering services include process design, failure analysis, reliability testing, tooling design, and real-time traceability system. Its manufacturing operations offer sensors, subsystems, customized optics, and optical modules and components. The company was founded by David Thomas Mitchell on August 12, 1999 and is headquartered in George Town, Cayman Islands.

Fabrinet

Fabrinet is drawing significant investor interest following a strong quarterly earnings report that featured a revenue and EPS beat alongside a raised outlook, confirming robust demand for its AI optical packaging services. While the community is actively debating the company's premium valuation and negative free cash flow metrics, many long-term shareholders remain bullish, viewing the recent volatility as an opportunity for entry amid the ongoing buildout of AI and hyperscale infrastructure.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is surging on significant investor enthusiasm following the FDA approval of its lead drug, Komzifti, with the community highlighting its best-in-class safety profile and once-daily dosing as key advantages over competitors. The conversation is heavily focused on the company's strong institutional backing, healthy cash reserves, and the potential for a transformative 2026 as it pushes into frontline AML indications and expands its solid tumor pipeline.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is trending as investors react to the launch of its second-generation autonomous trucks, with the community actively debating the timing of commercial scaling and the impact of the company's deepening partnership ecosystem. Sentiment remains heavily focused on potential catalysts ahead of upcoming earnings, with long-term investors highlighting the technology's production readiness while others closely monitor short-selling activity and market volatility.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending as market participants weigh a major pending antitrust judgment against Google alongside a new partnership with Apple for a device-leasing program. Investors are actively discussing the stock's potential for a re-rating if these catalysts drive profitability or expansion, even as some traders caution about volatility and the impact of broader fintech sector performance on the share price.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals is trending as investors focus on the upcoming Phase 3 LUCIDITY trial results for avexitide in post-bariatric hypoglycemia, with recent analyst upgrades and institutional positioning driving strong sentiment. Community discussions are centered on the company's solid cash runway extending through 2028 and the potential for a transformative impact in the underserved metabolic and endocrine markets.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors digest the company's progress toward a Q4 2026 NDA submission for AXPAXLI, a catalyst further bolstered by FDA alignment that removes the requirement for SOL-R efficacy data. While bullish community sentiment focuses on the companys potential to disrupt the wet AMD market and its status as a high-conviction buyout candidate, discussions remain polarized by persistent debates over trial design, competitive dynamics with EyePoint Pharmaceuticals, and the impact of the company's short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
